Zimmer Biomet ( NYSE:ZBH – Get Rating ) ‘s stock had its 'maintains' rating reiterated by research analysts at 58.com in a report released on Wednesday, Benzinga reports. Several other research firms have also commented on ZBH. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Zimmer Biomet from $121.00 to $147.00 in a research report on Wednesday. TheStreet raised shares of Zimmer Biomet from a 'c' rating to a 'b' rating in a research note on Tuesday. UBS Group assumed coverage on shares of Zimmer Biomet in a research note on Tuesday, March 28th.

https://www.dailypolitical.com/2023/05/05/zimmer-biomet-nysezbh-given-maintains-rating-at-58-com.html

#dailypolitical